Get started
Author

Kapil Vachhani

Observed names: Kapil J. Vachhani, Kapil V. Vachhani
Observed institution: Cadila Pharmaceuticals (India)
ORCID: 0000-0002-0799-9991
Observed ORCID: 0000-0002-0799-9991
OpenAlex ID: A5042261034
Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies
2011 · Paresh Dadhaniya, Chintan Patel, et al. · Food and Chemical Toxicology · 87
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
2019 · Michael A. O’Donnell, Sharwan Singh, et al. · Bladder Cancer · 10
Safety evaluation of the genotoxicity and subchronic toxicity of standardized Bacopa extract (Bacognize®) from Bacopa monnieri
2023 · Jayesh Muchhara, Kapil Vachhani, et al. · Toxicology Research and Application · 6
Assesment of 28 days repeated adminstration toxicity profile of dexamethasone palmitate injection
2015 · Ganesh N Sharma, Shaili Rasania, et al. · Journal of Nepal Pharmaceutical Association · 3
PDF
Desmocollin-3 and Bladder Cancer
2025 · Chandreshwar P. Shukla, Nayan K. Jain, et al. · Diseases · 1
PDF
Abstract 5265: Investigating the role of Desmocollin-3 and immune infiltrate in bladder cancer
2023 · Chandreshwar P. Shukla, Nayan K. Jain, et al. · Cancer Research
A 28 days oral toxicity of Dronedarone in Wistar Rats (Rattus norvegicus)
2017 · Rohit Parmar, Dilip Joshi, et al. · Journal of animal research
Works count: 7
Citation count: 107
H-index: 3
I10-index: 2
Year
Topic
Type